Efficacy of an enzyme immunoassay with uncentrifuged first-voided urine for detection of gonorrhea in males.
An enzyme immunoassay (Gonozyme; Abbott Laboratories, North Chicago, Ill.) for detection of Neisseria gonorrhoeae antigens was used to screen 184 urethral or uncentrifuged first-voided urine or both specimens from males and 78 cervical specimens. When compared with culture, the sensitivity and specificity of Gonozyme for cervical and urethral specimens were comparable to those in published reports. The sensitivity and specificity for urine specimens were 91.6 and 97.9%, respectively.
D000942:Antigens, Bacterial / Q000652:urine*; D002498:Centrifugation; D002584:Cervix Uteri / Q000382:microbiology; D005069:Evaluation Studies as Topic; D005260:Female; D006069:Gonorrhea / Q000175:diagnosis*; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D009344:Neisseria gonorrhoeae / Q000276:immunology; D014521:Urethra / Q000382:microbiology
D000942:Antigens, Bacterial